{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T17:27:55Z","timestamp":1786382875403,"version":"build-2736575974"},"reference-count":32,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Ophthalmology"],"DOI":"10.1080\/08820538.2026.2716333","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:30:27Z","timestamp":1786379427000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Aceclidine in Presbyopia, a Systematic Review and Meta -Analysis"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6970-8261","authenticated-orcid":false,"given":"Taha","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Dow University of Health Sciences","place":["Karachi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7034-5594","authenticated-orcid":false,"given":"Muhammad","family":"Burhan","sequence":"additional","affiliation":[{"name":"Dow University of Heath Sciences","place":["Karachi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1587-4320","authenticated-orcid":false,"given":"Shaheer","family":"Bin Shafiq","sequence":"additional","affiliation":[{"name":"Dow University of Heath Sciences","place":["Karachi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8471-4261","authenticated-orcid":false,"given":"Muhammad Junaid","family":"Razzak","sequence":"additional","affiliation":[{"name":"Dow University of Heath Sciences","place":["Karachi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8637-609X","authenticated-orcid":false,"given":"Ayesha Ahmed","family":"Khan","sequence":"additional","affiliation":[{"name":"Dow University of Heath Sciences","place":["Karachi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2387-8472","authenticated-orcid":false,"given":"Zain Ul Abideen","family":"Shahid","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences","place":["Karachi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4497-2185","authenticated-orcid":false,"given":"Mudassir","family":"Shahnawaz","sequence":"additional","affiliation":[{"name":"Dow University of Heath Sciences","place":["Karachi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5483-5273","authenticated-orcid":false,"given":"Saud Ur","family":"Rehman","sequence":"additional","affiliation":[{"name":"Dow University of Heath Sciences","place":["Karachi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8976-4906","authenticated-orcid":false,"given":"Jawaria","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hamdard University College of Medicine and Dentistry, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2953-2188","authenticated-orcid":false,"given":"Hashem","family":"Abu Serhan","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation","place":["Doha, Qatar"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"e_1_3_9_2_1","unstructured":"Mayo clinic presbyopia-symptoms and causes. https:\/\/www.mayoclinic.org\/diseases-conditions\/presbyopia\/symptoms-causes\/syc-20363328. Accessed March 27 2026."},{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.04.013"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S269597"},{"issue":"122","key":"e_1_3_9_5_1","first-page":"3","article-title":"Global uncorrected refractive error and presbyopia: the size of the problem","volume":"37","author":"Bastawrous A","year":"2024","unstructured":"Bastawrous A, Kassalow J, Watts E. Global uncorrected refractive error and presbyopia: the size of the problem. Community Eye Health. 2024;37(122):3\u20134.","journal-title":"Community Eye Health"},{"key":"e_1_3_9_6_1","unstructured":"Mayo Clinic Aceclidine. https:\/\/www.mayoclinic.org\/drugs-supplements\/aceclidine-ophthalmic-route\/description\/drg-80008487. Accessed March 27 2026."},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051385"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.4081\/ejtm.2022.10781"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_9_10_1","unstructured":"PROSPERO Registration(CRD420261353653). https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261353653."},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_9_13_1","unstructured":"LENZ Therapeutics I. Evaluation of the safety and effectiveness of aceclidine (LNZ101) and aceclidine + Brimonidine (LNZ100) in the treatment of presbyopia (NCT05431543). https:\/\/clinicaltrials.gov\/study\/NCT05431543?term=Aceclidine&rank=1. 2024. Accessed April 6 2026."},{"key":"e_1_3_9_14_1","unstructured":"LENZ Therapeutics I. Evaluation of the Safety and Effectiveness of Aceclidine\/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia(NCT05294328). 2024."},{"key":"e_1_3_9_15_1","unstructured":"LENZ Therapeutics I. A Single-Center Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia (NCT03201562). 2022."},{"key":"e_1_3_9_16_1","unstructured":"LENZ Therapeutics I. Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia. 2026 (CLARITY 2)(NCT05728944)."},{"key":"e_1_3_9_17_1","unstructured":"LENZ Therapeutics I. Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia (CLARITY 1) (NCT05656027). 2026."},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2018.09.004"},{"key":"e_1_3_9_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.12.1731"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1998.14.363"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000308677"},{"key":"e_1_3_9_22_1","unstructured":"Higgins JT. Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024). Cochrane 2024. www.cochrane.org\/handbook. 2024. Accessed April 6 2026."},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aopr.2024.09.001"},{"key":"e_1_3_9_24_1","unstructured":"abbvie U.S. Food and Drug Administration Approves VUITY. https:\/\/news.abbvie.com\/2021-10-29-U-S-Food-and-Drug-Administration-Approves-VUITY-TM-pilocarpine-HCI-ophthalmic-solution-1-25- -the-First-and-Only-Eye-Drop-to-Treat-Presbyopia-Age-Related-Blurry-Near-Vision. Accessed March 27 2026."},{"key":"e_1_3_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2025.08.033"},{"key":"e_1_3_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2024.10.035"},{"key":"e_1_3_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2022.05.011"},{"key":"e_1_3_9_28_1","article-title":"VEGA-1 phase 2 trial: phentolamine ophthalmic solution maintains pupillary light reflex with improved distance-corrected near vision in Presbyopes","author":"Patel R","year":"2023","unstructured":"Patel R, Brigell MG, Stuart Pepose J, Haddad L, Coleman D. VEGA-1 phase 2 trial: phentolamine ophthalmic solution maintains pupillary light reflex with improved distance-corrected near vision in Presbyopes. Invest Ophthalmol Vis Sci. 2023;68(4):2507.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_9_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000137"},{"key":"e_1_3_9_30_1","unstructured":"Adis insight Ursodeoxycholic acid - Santen Pharmaceutical. https:\/\/adisinsight.springer.com\/drugs\/800069908. 2024. Accessed March 27 2026."},{"key":"e_1_3_9_31_1","unstructured":"Santen. Pipeline development status (clinical stage). https:\/\/www.santen.com\/content\/dam\/santen\/global\/pdf\/en\/business\/pipeline.pdf. 2024. Accessed March 27 2026."},{"key":"e_1_3_9_32_1","unstructured":"PharmaPhorum Novartis drops presbyopia drug acquired with Encore Vision. https:\/\/pharmaphorum.com\/news\/novartis-drops-presbyopia-drug-acquired-with-encore-vision. Accessed March 27 2026."},{"key":"e_1_3_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2025.08.033"}],"container-title":["Seminars in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/08820538.2026.2716333","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/08820538.2026.2716333","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/08820538.2026.2716333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:30:31Z","timestamp":1786379431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/08820538.2026.2716333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":32,"alternative-id":["10.1080\/08820538.2026.2716333"],"URL":"https:\/\/doi.org\/10.1080\/08820538.2026.2716333","relation":{},"ISSN":["0882-0538","1744-5205"],"issn-type":[{"value":"0882-0538","type":"print"},{"value":"1744-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}